Health, Fitness & Food

In this article LLY Follow your favorite stocksCREATE FREE ACCOUNT The Eli Lilly logo is shown on one of the company’s offices in San Diego, California, on Sept. 17, 2020. Mike Blake | Reuters Eli Lilly on Thursday reported second-quarter earnings and revenue that blew past expectations and hiked its full-year revenue outlook by $3

Novo Nordisk Wegovy manufactured by Novo Nordisk packaging is seen in this illustration photo taken in a pharmacy in Krakow, Poland on April 8, 2024. (Photo by Jakub Porzycki/NurPhoto via Getty Images) Jakub Porzycki | Nurphoto | Getty Images Novo Nordisk on Wednesday posted weaker-than-expected net profit in the second quarter and trimmed its operating

In this article CVS Follow your favorite stocksCREATE FREE ACCOUNT The CVS pharmacy logo is displayed on a sign above a CVS Health Corp. store in Las Vegas, Nevada on Feb. 7, 2024. Patrick T. Fallon | AFP | Getty Images CVS Health on Wednesday reported second-quarter earnings that topped expectations, but slashed its full-year

In this article JNJ BMY Follow your favorite stocksCREATE FREE ACCOUNT President Joe Biden speaks during an event at the National Institutes of Health in Bethesda, Maryland, Dec. 14, 2023. Chris Kleponis | Bloomberg | Getty Images Think a friend or colleague should be getting this newsletter? Share this link with them to sign up.

GE Healthcare on Wednesday morning reported a mixed second quarter and shares initially moved sharply lower. The stock then reversed higher as the post-earnings call got underway. Management made it clear that they think that weakness in China is temporary and see many other levers available to grow earnings. Revenue advanced less than 1% year over

In this article LLY NOVO.B-DK AUGX Follow your favorite stocksCREATE FREE ACCOUNT Weight loss syringes of the brands “Wegovy”, “Ozempic” and “Mounjaro” are sold at In der Achat Apotheke in Mitte, Germany. Picture Alliance | Picture Alliance | Getty Images Think a friend or colleague should be getting this newsletter? Share this link with them

The Moderna Inc. headquarters in Cambridge, Massachusetts, US, on Tuesday, March 26, 2024.  Adam Glanzman | Bloomberg | Getty Images Moderna on Thursday reported second-quarter revenue that beat expectations but slashed its full-year sales guidance, citing lower expected sales in Europe, a “competitive environment” for respiratory vaccines in the U.S. and the potential for deferred

In this article LLY Follow your favorite stocksCREATE FREE ACCOUNT An injection pen of Zepbound, Eli Lilly’s weight loss drug, is displayed in New York City on Dec. 11, 2023. Brendan McDermid | Reuters All doses of Eli Lilly’s highly popular weight loss injection Zepbound and diabetes drug Mounjaro are now available in the U.S.,

A test tube is seen in front of displayed Biogen logo in this illustration taken on, December 1, 2021. Dado Ruvic | Reuters Biogen on Thursday reported second-quarter earnings and revenue that topped estimates and hiked its full-year guidance, as the company’s cost cuts showed progress and sales of its breakthrough Alzheimer’s drug, Leqembi, and

The eponymous sign outside Epic headquarters in Verona, Wisconsin. Source: Yiem via Wikipedia CC It’s about to get a lot easier for patients in the U.S. to access their own medical records.  Health-care software vendor Epic Systems on Thursday announced that individuals will be able to securely release their health data to different apps they

In this article LLY Follow your favorite stocksCREATE FREE ACCOUNT An Eli Lilly & Co. Zepbound injection pen arranged in the Brooklyn borough of New York, US, on Thursday, March 28, 2024.  Shelby Knowles | Bloomberg | Getty Images Eli Lilly‘s weight loss drug Zepbound showed benefits in patients with a common type of heart

In this article ME Follow your favorite stocksCREATE FREE ACCOUNT A sign is posted in front of the 23andMe headquarters in Sunnyvale, California, on Feb. 1, 2024. Justin Sullivan | Getty Images Anne Wojcicki, CEO of 23andMe, has submitted a proposal to take the genetic testing company private as its stock price continues to hover

Every weekday, the CNBC Investing Club with Jim Cramer releases the Homestretch — an actionable afternoon update, just in time for the last hour of trading on Wall Street. Market slides : The S & P 500 gave back earlier gains and fell throughout Tuesday afternoon, led lower by the mega-cap tech stocks. Ahead of the

In this article 4523.T-JP Follow your favorite stocksCREATE FREE ACCOUNT The newly FDA approved Alzheimer’s treatment Leqembi is prepared at Abington Neurological Associates in Abington, PA., on Tuesday, November 7, 2023.  Hannah Yoon | The Washington Post | Getty Images The breakthrough Alzheimer’s drug Leqembi slowed disease progression in patients over three years, demonstrating the

In this article AAPL Follow your favorite stocksCREATE FREE ACCOUNT Mark uses the Vision Pro with his BCI Courtesy of Synchron Neurotech startup Synchron on Tuesday announced it has connected its brain implant to Apple‘s Vision Pro headset. It’s now possible for patients with limited physical mobility to control the device using only their thoughts. 

Every weekday, the CNBC Investing Club with Jim Cramer releases the Homestretch — an actionable afternoon update, just in time for the last hour of trading on Wall Street. Market moves: The S & P 500 was on track for small gains following a solid rally last Friday. There’s still some market rotation happening, but

In this article AMZN GEHC Follow your favorite stocksCREATE FREE ACCOUNT Jakub Porzycki | Nurphoto | Getty Images GE HealthCare on Thursday announced it is teaming up with Amazon Web Services to build new generative artificial intelligence models and tools that can efficiently analyze complex medical data. The health-care industry is responsible for generating nearly

In this article LLY VKTX NOVO.B-DK Follow your favorite stocksCREATE FREE ACCOUNT Weight loss drug concept. Cr | Istock | Getty Images Shares of Viking Therapeutics jumped more than 20% on Thursday after the biotech company a day earlier announced plans to advance its experimental weight loss injection into a late-stage trial earlier than expected. 

In this article 4523.T-JP BIIB Follow your favorite stocksCREATE FREE ACCOUNT Eisai | via Reuters European drug regulators on Friday rejected the Alzheimer’s treatment Leqembi from Biogen and Eisai, creating another hurdle for the companies as they scramble to boost uptake of the therapy in the U.S.  The European Commission, the EU’s executive body, has

Every weekday the CNBC Investing Club with Jim Cramer holds a “Morning Meeting” livestream at 10:20 a.m. ET. Here’s a recap of Friday’s key moments. Stocks jumped Friday as Wall Street tried to end a turbulent week on a jubilant note. The Dow Jones Industrial Average added more more than 600 points, or 1.6%. The